Literature DB >> 23507969

FBW7 regulates endothelial functions by targeting KLF2 for ubiquitination and degradation.

Rui Wang1, Yan Wang, Ning Liu, Chunguang Ren, Cong Jiang, Kai Zhang, Su Yu, Yunfei Chen, Hui Tang, Qi Deng, Cong Fu, Yingcong Wang, Rong Li, Mingyao Liu, Weijun Pan, Ping Wang.   

Abstract

F-box and WD repeat domain-containing 7 (FBW7), the substrate-binding subunit of E3 ubiquitin ligase SCF(FBW7) (a complex of SKP1, cullin-1 and FBW7), plays important roles in various physiological and pathological processes. Although FBW7 is required for vascular development, its function in the endothelium remains to be investigated. In this study, we show that FBW7 is an important regulator of endothelial functions, including angiogenesis, leukocyte adhesion and the endothelial barrier integrity. Using RNA interference, we found that the depletion of FBW7 markedly impairs angiogenesis in vitro and in vivo. We identified the zinc finger transcription factor Krüppel-like factor 2 (KLF2) as a physiological target of FBW7 in endothelial cells. Knockdown of FBW7 expression resulted in the accumulation of endogenous KLF2 protein in endothelial cells. FBW7-mediated KLF2 destruction was shown to depend on the phosphorylation of KLF2 via glycogen synthase kinase-3 (GSK3) at two conserved phosphodegrons. Mutating these phosphodegron motifs abolished the FBW7-mediated degradation and ubiquitination of KLF2. The siRNA-mediated knockdown of FBW7 showed that KLF2 is an essential target of FBW7 in the regulation of endothelial functions. Moreover, FBW7-mediated KLF2 degradation was shown to be critical for angiogenesis in teratomas and in zebrafish development. Taken together, our study suggests a role for FBW7 in the processes of endothelial cell migration, angiogenesis, inflammation and barrier integrity, and provides novel insights into the regulation of KLF2 stability in vivo.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23507969      PMCID: PMC3674386          DOI: 10.1038/cr.2013.42

Source DB:  PubMed          Journal:  Cell Res        ISSN: 1001-0602            Impact factor:   25.617


  59 in total

1.  A comparison of primary endothelial cells and endothelial cell lines for studies of immune interactions.

Authors:  E A Lidington; D L Moyes; A M McCormack; M L Rose
Journal:  Transpl Immunol       Date:  1999-12       Impact factor: 1.708

Review 2.  Endothelial-dependent mechanisms of leukocyte recruitment to the vascular wall.

Authors:  Ravi M Rao; Lin Yang; Guillermo Garcia-Cardena; Francis W Luscinskas
Journal:  Circ Res       Date:  2007-08-03       Impact factor: 17.367

3.  The Fbw7 tumor suppressor targets KLF5 for ubiquitin-mediated degradation and suppresses breast cell proliferation.

Authors:  Dong Zhao; Han-Qiu Zheng; Zhongmei Zhou; Ceshi Chen
Journal:  Cancer Res       Date:  2010-05-18       Impact factor: 12.701

4.  SAG/RBX2/ROC2 E3 ubiquitin ligase is essential for vascular and neural development by targeting NF1 for degradation.

Authors:  Mingjia Tan; Yongchao Zhao; Sun-Jung Kim; Margaret Liu; Lijun Jia; Thomas L Saunders; Yuan Zhu; Yi Sun
Journal:  Dev Cell       Date:  2011-11-23       Impact factor: 12.270

5.  Negative regulation of the stability and tumor suppressor function of Fbw7 by the Pin1 prolyl isomerase.

Authors:  Sang-Hyun Min; Alan W Lau; Tae Ho Lee; Hiroyuki Inuzuka; Shuo Wei; Pengyu Huang; Shavali Shaik; Daniel Yenhong Lee; Greg Finn; Martin Balastik; Chun-Hau Chen; Manli Luo; Adriana E Tron; James A Decaprio; Xiao Zhen Zhou; Wenyi Wei; Kun Ping Lu
Journal:  Mol Cell       Date:  2012-05-17       Impact factor: 17.970

Review 6.  The ubiquitous nature of cancer: the role of the SCF(Fbw7) complex in development and transformation.

Authors:  K M Crusio; B King; L B Reavie; I Aifantis
Journal:  Oncogene       Date:  2010-06-14       Impact factor: 9.867

Review 7.  Emerging roles of the FBW7 tumour suppressor in stem cell differentiation.

Authors:  Zhiwei Wang; Hiroyuki Inuzuka; Hidefumi Fukushima; Lixin Wan; Daming Gao; Shavali Shaik; Fazlul H Sarkar; Wenyi Wei
Journal:  EMBO Rep       Date:  2011-12-23       Impact factor: 8.807

8.  Fbxw7/Cdc4 is a p53-dependent, haploinsufficient tumour suppressor gene.

Authors:  Jian-Hua Mao; Jesus Perez-Losada; Di Wu; Reyno Delrosario; Ryosuke Tsunematsu; Keiichi I Nakayama; Ken Brown; Sheila Bryson; Allan Balmain
Journal:  Nature       Date:  2004-12-09       Impact factor: 49.962

9.  WWP1-dependent ubiquitination and degradation of the lung Krüppel-like factor, KLF2.

Authors:  Xiaoling Zhang; Seetha V Srinivasan; Jerry B Lingrel
Journal:  Biochem Biophys Res Commun       Date:  2004-03-26       Impact factor: 3.575

10.  Mir-144 selectively regulates embryonic alpha-hemoglobin synthesis during primitive erythropoiesis.

Authors:  Yan-Fang Fu; Ting-Ting Du; Mei Dong; Kang-Yong Zhu; Chang-Bin Jing; Yong Zhang; Lei Wang; Hong-Bo Fan; Yi Chen; Yi Jin; Gui-Ping Yue; Sai-Juan Chen; Zhu Chen; Qiu-Hua Huang; Qing Jing; Min Deng; Ting Xi Liu
Journal:  Blood       Date:  2008-10-21       Impact factor: 22.113

View more
  33 in total

1.  Suppression of glioblastoma by targeting the overactivated protein neddylation pathway.

Authors:  Wei Hua; Chunjie Li; Zixiao Yang; Lihui Li; Yanan Jiang; Guangyang Yu; Wei Zhu; Zhengyan Liu; Shengzhong Duan; Yiwei Chu; Meng Yang; Yanmei Zhang; Ying Mao; Lijun Jia
Journal:  Neuro Oncol       Date:  2015-04-22       Impact factor: 12.300

2.  Cell cycle-dependent degradation of the methyltransferase SETD3 attenuates cell proliferation and liver tumorigenesis.

Authors:  Xiaoqing Cheng; Yuan Hao; Wenjie Shu; Mengjie Zhao; Chen Zhao; Yuan Wu; Xiaodan Peng; Pinfang Yao; Daibiao Xiao; Guoliang Qing; Zhengying Pan; Lei Yin; Desheng Hu; Hai-Ning Du
Journal:  J Biol Chem       Date:  2017-04-25       Impact factor: 5.157

3.  The FBW7-KLF2 axis regulates endothelial functions.

Authors:  Yongchao Zhao; Yi Sun
Journal:  Cell Res       Date:  2013-04-09       Impact factor: 25.617

4.  Elevated PTH induces endothelial-to-chondrogenic transition in aortic endothelial cells.

Authors:  Min Wu; Jian-Dong Zhang; Ri-Ning Tang; Steven D Crowley; Hong Liu; Lin-Li Lv; Kun-Ling Ma; Bi-Cheng Liu
Journal:  Am J Physiol Renal Physiol       Date:  2016-08-31

5.  Fine-Tuning of the RIG-I-Like Receptor/Interferon Regulatory Factor 3-Dependent Antiviral Innate Immune Response by the Glycogen Synthase Kinase 3/β-Catenin Pathway.

Authors:  Kashif Aziz Khan; Florence Dô; Alexandre Marineau; Priscilla Doyon; Jean-François Clément; James R Woodgett; Bradley W Doble; Marc J Servant
Journal:  Mol Cell Biol       Date:  2015-06-22       Impact factor: 4.272

Review 6.  Krüppel-like factors in mammalian stem cells and development.

Authors:  Agnieszka B Bialkowska; Vincent W Yang; Sandeep K Mallipattu
Journal:  Development       Date:  2017-03-01       Impact factor: 6.868

7.  CK1δ/GSK3β/FBXW7α axis promotes degradation of the ZNF322A oncoprotein to suppress lung cancer progression.

Authors:  S-Y Liao; C-W Chiang; C-H Hsu; Y-T Chen; J Jen; H-F Juan; W-W Lai; Y-C Wang
Journal:  Oncogene       Date:  2017-06-05       Impact factor: 9.867

Review 8.  Targeting the ubiquitin pathway for cancer treatment.

Authors:  Jia Liu; Shavali Shaik; Xiangpeng Dai; Qiong Wu; Xiuxia Zhou; Zhiwei Wang; Wenyi Wei
Journal:  Biochim Biophys Acta       Date:  2014-12-04

9.  Peripheral tolerance can be modified by altering KLF2-regulated Treg migration.

Authors:  Sudheer K Pabbisetty; Whitney Rabacal; Emmanuel J Volanakis; Vrajesh V Parekh; Danyvid Olivares-Villagómez; Delphine Cendron; Kelli L Boyd; Luc Van Kaer; Eric Sebzda
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-26       Impact factor: 11.205

10.  The 11S Proteasome Subunit PSME3 Is a Positive Feedforward Regulator of NF-κB and Important for Host Defense against Bacterial Pathogens.

Authors:  Jinxia Sun; Yi Luan; Dong Xiang; Xiao Tan; Hui Chen; Qi Deng; Jiaojiao Zhang; Minghui Chen; Hongjun Huang; Weichao Wang; Tingting Niu; Wenjie Li; Hu Peng; Shuangxi Li; Lei Li; Wenwen Tang; Xiaotao Li; Dianqing Wu; Ping Wang
Journal:  Cell Rep       Date:  2016-01-14       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.